For over 25 years, Susan Dallabrida has served as a leader in clinical trials, healthcare, and eClinical technology for biopharmaceutical and health-related consumer goods companies. Her career began at Harvard Medical School—where she served as Principal Investigator and Lab Director at the Children's Hospital—before she transitioned into new roles with Biogen, ERT, Oracle Health Sciences. Dallabrida holds a doctorate from Pennsylvania State University, College of Medicine, with a Ph.D. in Biochemistry and Molecular Biology. At ObvioHealth, Susan leads rater, patient, and caregiver training, as well as ePRO, ClinRo, and instrument development and validation.
Craig Gravina has over 25 years’ experience developing highly innovative platforms, products, and disruptive technologies within healthcare and life sciences. He has managed several successful developments and launches across the industry, including a digital therapy platform for Leso Digital Health, cognitive assessment solutions at Cogstate, and an analytics and population health platform and portfolio at Allscripts. In his work with ObvioHealth, Craig and his team have architected a next-generation healthcare platform and introduced innovative product capabilities across the venture portfolio.
Liberating the genetics, laboratory and pharmacy data that sits deep within healthcare subsystems, while protecting patient information and navigating the global regulatory landscape, is no easy task but would greatly help in the treatment of diseases.